GENE ONLINE|News &
Opinion
Blog

Phase 2 Trial
Trials & Approvals Parkinson’s Disease
Praxis Stock Hits All-Time Low After Phase 2 Tremor Data Released
2023-03-06
Trials & Approvals HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Trials & Approvals Pfizer
Pfizer’s Potential GBS Vaccines Swipes Up the FDA’s Breakthrough Therapy Designation
2022-09-07
Trials & Approvals NSCLC
Jounce’s Antibody Misses Primary Endpoint In Phase 2 Lung Cancer Study
2022-08-31
Trials & Approvals Heart Disease
Cytokinetics Poised to Begin Phase 3 after its HCM Drug Registers Encouraging Data
2021-07-21
Trials & Approvals INTERACT Study
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
Trials & Approvals Immutep
Immutep Announces Discontinuation of Phase 2 Ulcerative Colitis Study by GSK
2021-01-30
Trials & Approvals Gene Therapy
Sarepta’s Stocks Drop 50% Following Middling Trial Data for Gene Therapy
2021-01-11
R&D LDL
Regeneron’s Antibody Therapy Reduces LDL Cholesterol in Hypercholesterolemia Patients
2020-11-21
Trials & Approvals Non-alcoholic Steatohepatitis
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
In-Depth AAT
With its AAT Deficiency Therapy Biting the Dust, Vertex Pins Hope on Second Drug
2020-10-16
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Trials & Approvals Alzheimer's Disease
Roche, AC Immune’s Alzheimer’s Drug Joins Long List of Trial Flops
2020-09-25
Trials & Approvals
ASCO 2020: Genentech’s Novel anti-TIGIT Therapy Shows Promise in Phase II Lung Cancer Trials
2020-05-31
Trials & Approvals Hepatitis
Gilead’s Antiviral Drug, Epclusa gets FDA Nod for Pediatric Hepatitis C
2020-03-22
1 2
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top